gvtcx

Securecell AG Numera and Lucullus Platform

CELL THERAPY CATAPULT LIMITED Published 17 Jun 2026 Find a Tender

key details

Statuscomplete
RegionNorth East, North West, Yorkshire and the Humber, East Midlands, West Midlands, East of England, London, South East, South West
Proceduredirect
SME suitableYes
OCIDocds-h6vhtk-06b72c

Award

SupplierValueDateStatus
Securecell AG - BPES £650,792 · pending

description

Over 2022/2023 CGT Catapult purchased the specialised Securecell AG Automation platform comprising Numera automatic sampling system and Lucullus software. The original SEA (dated 27th May 2022) for that purchase had total amount of £590,149 and a duration of 5 years. This year as we approach a total spend with Securecell AG approaching this balance we need to justify a new direct award to enable continued access to hardware and software support for the platform through a Service Level Agreement (SLA).

The Securecell AG Numera and Lucullus platform is highly specialised and Securecell AG are the only provider of this equipment and software. See Single Suppliers 6) in the guidance notes below. Additionally, no other providers of equipment and software support services are expected to be able to provide the required SLA.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
17 Jun 2026 Transparency notice (UK5) Procurement Act 2023 057196-2026

more from CELL THERAPY CATAPULT LIMITED

all contracts from this buyer →

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.